STARN ENERGY SERVICES GROUP LIMITED
Company number SC466142 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Starn Energy Services Group Limited
1. Financial Health Score: F
This company is in critical condition. The financial vital signs indicate severe insolvency, with liabilities exceeding assets by over £52 million and auditors explicitly flagging a material uncertainty regarding going concern. This is the financial equivalent of a patient in intensive care — survival depends entirely on continued external life support (in this case, group and banking facilities).
2. Key Vital Signs
| Vital Sign | 2025 | 2024 | 2023 | 2022 | Trend |
|---|---|---|---|---|---|
| Net Assets | -£52.1M | -£41.2M | -£35.4M | -£29.7M | 📉 Deteriorating |
| Shareholders' Funds | -£56.6M | -£45.7M | -£39.9M | -£34.2M | 📉 Deteriorating |
| Cash | £475,758 | £1,669 | £2,734 | £1,364 | 📈 Improved (from critical base) |
| Total Assets | £28.2M | £34.0M | £32.5M | £31.8M | 📉 Declining |
| Total Liabilities | £72.4M | £66.7M | £59.9M | £54.9M | 📉 Growing |
Interpretation of Critical Metrics
Net Assets (-£52.1M): This is the most alarming indicator. The company's liabilities exceed its assets by over £52 million — a figure that has worsened by approximately £10.9 million in just one year. In medical terms, this is a patient whose vital organs are failing progressively. The negative trajectory has been consistent and accelerating over four years.
Cash Position (£475,758): While this represents a dramatic improvement from the near-zero levels of previous years (£1,669 in 2024), context is essential. This cash is dwarfed by the £72.4 million in liabilities. Imagine a patient with £475 in their pocket but £72,400 in medical bills — the improvement is notable but insufficient to change the prognosis.
Shareholders' Funds (-£56.6M): The equity position has deteriorated by nearly £11 million in one year. This indicates the company is haemorrhaging value, with accumulated losses consuming any remaining capital base.
Liability-to-Asset Ratio (2.57x): Total liabilities are 2.57 times total assets. A healthy company typically maintains this ratio below 0.5x. At 2.57x, this indicates extreme leverage and insolvency.
3. Diagnosis
Primary Condition: Balance Sheet Insolvency with Going Concern Uncertainty
The diagnosis is unambiguous: this company is insolvent on a balance sheet basis and is only continuing to trade due to group support and banking facilities.
The auditor's report contains a rare and serious warning — a material uncertainty related to going concern. In medical terms, this is equivalent to a doctor noting that the patient's survival depends on continued external intervention, and that intervention is not guaranteed. Specifically, the auditors highlight:
"Significant uncertainty facing the company in terms of continued support from the group's banking provider as well as certain courses of action being taken by the directors."
This is not a routine caution. It signals that the auditors cannot obtain reasonable assurance that the company can continue trading without additional support.
Secondary Conditions
Concentration Risk: The company has only three principal investments (Safehouse Habitats, Sabre Safety Services, and Starn Canada Inc.). This portfolio concentration means that the failure of any single investment could be terminal — akin to a patient with only three vital organs, where failure of any one is catastrophic.
Structural Dependency: As a holding company, Starn Energy Services Group Limited has no independent revenue-generating operations. Its financial health is entirely dependent on the performance of subsidiaries and the willingness of the parent (Starn Group Limited) and banking providers to continue funding. This is a structural vulnerability — the patient cannot survive without a ventilator.
Deteriorating Trajectory: Net assets have worsened by approximately £22.4 million over four years (from -£29.7M to -£52.1M), representing an average annual deterioration of approximately £5.6 million. This is not a stable condition — it is progressively worsening.
What the Numbers Reveal About Underlying Health
The company's financial statements tell a story of an investment holding company whose investments have underperformed relative to the debt and obligations taken on to acquire and support them. The growing negative equity suggests that:
- Impairment losses may be eroding asset values
- Interest and financing costs are accumulating faster than investment returns
- Group-level debt is being serviced through this entity, creating a debt burden far exceeding asset values
4. Recommendations
Immediate Actions (Critical — Within 30 Days)
-
Urgent Going Concern Assessment: The board must formally assess and document the basis on which the company can continue as a going concern. This requires confirmed, written commitments from Starn Group Limited and banking providers regarding continued financial support. Without these, the directors face personal liability risks.
-
Cash Conservation: Implement strict cash management protocols. While the improved cash position is encouraging, the company remains one unexpected demand away from insolvency.
-
Director Responsibilities Review: Given the going concern uncertainty, directors should seek professional advice regarding their duties under the Insolvency Act 1986, particularly Section 122 regarding wrongful trading. If the company cannot meet its debts as they fall due, directors must act responsibly to minimise creditor losses.
Short-Term Actions (1-6 Months)
-
Debt Restructuring: Engage with banking providers and the parent company to restructure liabilities. Options include: - Debt-for-equity swaps at group level - Extension of loan maturity dates - Capitalisation of intercompany obligations
-
Portfolio Review: Conduct a rigorous review of the three principal investments (Safehouse, Sabre, and Starn Canada). Determine whether these investments can realistically recover to values that support the debt burden, or whether strategic disposals should be considered.
-
Stakeholder Communication: Provide transparent communication to key stakeholders, including the parent company, banking providers, and employees of subsidiary companies, about the financial position and recovery plans.
Medium-Term Actions (6-18 Months)
-
Equity Injection: The parent company (Starn Group Limited) must consider a significant capital injection to restore positive net asset position. Without this, the company remains technically insolvent and vulnerable to any withdrawal of support.
-
Strategic Options Assessment: Consider whether the current holding structure is optimal. The concentration risk of three investments, combined with the debt burden, may warrant: - Divestiture of one or more investments to reduce debt - Merger or restructuring within the group - In extremis, administration or pre-pack sale of viable subsidiary operations
-
Performance Improvement Plans: For each subsidiary investment, implement rigorous performance improvement programmes with clear milestones and accountability. The strategic report notes that "underlying investments continue to demonstrate resilience" — this must translate into tangible asset value growth.
5. Prognosis
The prognosis is guarded to poor without significant intervention.
The company's survival currently depends on two external factors beyond its direct control: continued banking support and continued parent company support. The auditor's material uncertainty regarding going concern means these supports cannot be guaranteed.
If group and banking support continues: - The company can trade through its current difficulties - However, the underlying trajectory (deteriorating net assets) must be reversed - Recovery will require both debt reduction and asset value growth
If support is withdrawn: - The company would likely enter formal insolvency - Given the £52 million deficit, unsecured creditors would face significant losses - The subsidiary investments may have value in a sale, but this would need to be realised quickly
The improved cash position in 2025 (£475,758 versus £1,669) is a small positive signal, possibly indicating better working capital management or reduced cash burn. However, this alone is insufficient to change the overall prognosis without structural changes to the balance sheet.